Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma
Background The aim of this research was to evaluate clinical and low-cost genetic determinants of treatment outcome in EGFR mutation positive advanced lung adenocarcinoma patients. Material and Methods EGFR mutation testing and EGFR 181946C>T genotyping were performed in 101 advanced lung adenoca...
Saved in:
Main Authors: | Vera Jokic (Author), Katarina Savic-Vujovic (Author), Jelena Spasic (Author), Zoran Bukumiric (Author), Mladen Marinkovic (Author), Davorin Radosavljevic (Author), Milena Cavic (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer
by: Jelena Spasic, et al.
Published: (2022) -
Correlation of Ionized Magnesium with the Parameters of Oxidative Stress as Potential Biomarkers in Patients with Anxiety and Depression: A Pilot Study
by: Ana Opanković, et al.
Published: (2022) -
EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy
by: Minhye Kim, et al.
Published: (2021) -
A case of concomitant EGFR/ALK alteration against a mutated EGFR background in early-stage lung adenocarcinoma
by: Ki-Chang Lee, et al.
Published: (2021) -
Concomitant EGFR mutation and ALK rearrangement in multifocal lung adenocarcinoma: a case report
by: Jun Fan, et al.
Published: (2020)